Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoclopramide and 5-HTP challenge crossover study of vasopressin and HPA-axis activation
NL-OMON31221Not yet recruiting
- Sponsor
- Centre for Human Drug Research
- Start
- Mar 2007
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial of metoclopramide and 5-hydroxytryptophan in major depressive disorder (MDD) (4 arms), sponsored by Centre for Human Drug Research. Primary endpoints: Plasma ACTH, Plasma total cortisol and 3 more. Planned start Mar 2007; status: not yet recruiting.
02
Drugs
metoclopramide5-hydroxytryptophan
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NL-OMON31221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31221.